Dipak Chattaraj
Director
generic pharmaceutical
NECTID
United States of America
Biography
Dipak Chattaraj was appointed to the company�s board of directors. Mr. Chattaraj was formerly the chairman of Ranbaxy USA, a global generic pharmaceutical company. With over 35 years of global experience, Mr. Dipak Chattaraj has played a key role in Ranbaxy�s global expansion, specifically in the US markets development. Mr. Chattaraj joined Ranbaxy in 1991and in 1996 he assumed responsibility for Ranbaxy�s U.S. operations. Mr. Chattaraj, who holds a Masters degree in Economics, recently retired as Ranbaxy�s President, Corporate Development.
Research Interest
generic pharmaceutical
